Message from the BOPA Research Committee

We are delighted to announce that we have received a record-breaking number of abstracts for the 2022 Symposium in Liverpool.  A crack team of markers are now in the process of reviewing all the abstracts and we are aiming to notify all lead authors by 2nd September if their work has been accepted.   The original abstract deadline has now closed but we will still be accepting “Late-Breaking Abstracts” (eligible for poster presentation but will not be considered for oral presentation) until Monday 8th August.  So if you have recently completed a piece of work that you would love to share, its not too late to put together and submit an abstract!

 

Submit here

Latest News

By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article
By BOPA on 27th October 2025

Celebrating Success in the BOPA Immunotherapy Group

The BOPA Immunotherapy Cancer Advisory Group, have recently done some research into immune-related cardiac toxicity; both the monitoring for, and management of, these rare but serious adverse effects. Simon Jenkinson,…

Read article
By BOPA on 27th October 2025

Celebrating Black History Month – Celebrating Excellence with Gisela Abbam

In celebration of Black History Month, the Kingston University BAME staff network  is excited to invite you to an inspiring session with Gisela Abbam,  Chair of the General Pharmaceutical Council (GPhC). Gisela…

Read article
By BOPA Committee on 26th October 2025

Immunotherapy Study Day at Royal Marsden Hospital

The team at the Royal Marsden Hospital are organising an immunotherapy study day on the 3rd December, please see link below for more information. A User Guide to Cancer Immunotherapy…

Read article